The scale of the problem begins with plastic production itself. Since the mid-twentieth century, synthetic polymers such as polyethylene, polypropylene, polystyrene, polyvinyl chloride, and polyethylene terephthalate have been manufactured in enormous quantities, and a substantial fraction has escaped into the environment. Through ultraviolet radiation, mechanical abrasion, and thermal stress, larger plastic items fragment into microplastics, particles generally defined as smaller than five millimeters. Weathering does not merely shrink these materials; it fundamentally alters their surface chemistry. Oxidation introduces oxygen-containing functional groups onto polymer surfaces, increases surface area through cracking, and changes surface charge, all of which influence how strongly other molecules adhere to the plastic. The review emphasizes that aged, weathered microplastics often behave very differently from pristine laboratory particles, generally adsorbing contaminants more readily because of their roughened, chemically activated surfaces.

The chemistry of contaminant adsorption onto microplastics is governed by several interacting mechanisms. Hydrophobic organic contaminants, including polycyclic aromatic hydrocarbons, polychlorinated biphenyls, organochlorine pesticides such as DDT, and polybrominated diphenyl ethers, tend to partition onto the hydrophobic surfaces of polyethylene and polypropylene in much the same way they bind to soil organic matter. Heavy metals such as lead and cadmium interact through electrostatic attraction, surface complexation with oxidized functional groups, and, in some cases, bridging via biofilm exudates. Pharmaceuticals and antibiotics display variable behavior depending on water chemistry, pH, and ionic strength. Per- and polyfluoroalkyl substances, the so-called forever chemicals prized for their water and grease resistance, present a particular paradox: although their fluorinated tails repel both water and oil, certain PFAS compounds nonetheless adsorb appreciably to microplastic surfaces, particularly where biofilms have colonized the plastic and extracellular polymeric substances provide additional binding sites.

That last point highlights one of the most dynamic aspects of microplastic contamination: the plastisphere. When microplastics enter aquatic or terrestrial environments, they rapidly acquire microbial biofilms, creating a distinct ecological niche on an artificial substrate. These biofilms change the game in multiple ways. They add sticky extracellular polymeric substances that enhance the capture of both organic chemicals and metals, they can alter local pH and redox conditions at the plastic surface, and they facilitate horizontal gene transfer, raising concerns that microplastics act as vectors for antibiotic resistance genes. Recent in situ studies cited in the review show that biofilm development on microplastics measurably increases PFAS adsorption in aquatic environments, meaning that a plastic particle drifting through a river is not a chemically inert object but an evolving platform whose cargo changes over time.

Once contaminant-laden microplastics form, they become mobile. Ocean currents, riverine flow, atmospheric transport, and even agricultural practices such as the application of sewage sludge and plastic mulch films distribute these particles across the planet, including to remote regions such as Antarctica and the deep ocean. Atmospheric modeling has suggested that airborne transport is a major pathway delivering microplastics to distant ecosystems, and indoor air itself carries a significant load of textile-derived synthetic fibers. Along this journey, microplastics transfer their chemical cargo through food webs. Plankton ingest particles, small predators eat contaminated plankton, and trophic transfer compounds exposure at higher levels, a phenomenon documented in littoral predators and in commercially harvested seafood such as mussels and fish. Because many of the adsorbed pollutants are persistent, bioaccumulative, and toxic, the review notes that plastic-mediated transport can move chemicals to locations and organisms that would otherwise experience far lower exposures.

Human exposure occurs through three principal routes: ingestion, inhalation, and dermal contact. Microplastics have been detected in table salt, bottled water, beer, honey, and seafood, and food packaging is a recognized source of contamination. Indoor environments, where synthetic textiles shed fibers continuously, contribute substantially to inhalation exposure; breathing simulation studies using thermal manikins have quantified the inhalation of airborne microplastic fibers in realistic indoor settings. Perhaps more striking is the accumulating evidence that these particles penetrate deep into the human body. Researchers have identified microplastics in human blood, lung tissue obtained during bronchoscopy, cirrhotic liver tissue, human stool, breast milk, placenta, and even the oral cavity. Particle size is a critical determinant of fate: larger fragments are likely to pass through the gut, while micrometer-scale and nanoplastic particles can be internalized by intestinal M cells, cross epithelial barriers, be taken up by macrophages, and distribute to distant organs. In the respiratory tract, modeled deposition patterns suggest that inhaled particles settle in different airway regions depending on size and shape, with the smallest particles reaching the alveolar region.

The toxicological question that the review frames most carefully is whether microplastics serve as meaningful vectors for chemical exposure, or whether the chemicals they carry would enter the body anyway through water and food. Earlier critical work, notably a model-supported reinterpretation of empirical studies, argued that for many hydrophobic organic contaminants, transfer from ingested plastic is minor compared with other dietary routes. The new review does not dismiss that caution, but it highlights scenarios in which the carrier role could matter substantially. Laboratory studies simulating human digestion have shown that PAHs adsorbed on microplastics can desorb in the gastrointestinal tract, and heavy metals bound to plastics can similarly be released under the acidic, enzyme-rich conditions of the gut. Weathered particles with high contaminant loads, or particles that concentrate chemicals locally at epithelial surfaces, may deliver boluses of toxicants that chronic low-level background exposure does not. Combined particle-chemical exposure has been associated in cell and animal studies with oxidative stress, generation of reactive oxygen species, inflammatory signaling, intestinal barrier damage, and apoptosis, effects that may exceed the sum of exposures to particles and chemicals separately.

A distinctive contribution of the review is its argument for bringing physiologically based pharmacokinetic modeling, or PBPK, into microplastic risk assessment. PBPK models divide the body into tissue compartments and use physiological parameters, blood flows, and tissue partitioning to simulate how a chemical is absorbed, distributed, metabolized, and excreted. The approach is well established in pharmaceutical development and has been applied by the same research group to compounds such as diethyl phthalate, nonylphenol, and isothiazolinone preservatives. Applied to microplastics, such models could predict internal doses of both the particles themselves and the chemicals desorbing from them, bridging the gap between environmental concentrations measured in water, food, and air and the concentrations that actually reach target tissues. The authors argue that this modeling framework, combined with better data on desorption behavior under digestive and pulmonary conditions, is essential for moving the field from hazard identification toward quantitative human health risk assessment.

The implications extend beyond human toxicology to ecosystem management and policy. Microplastics in soil plastispheres have been identified as hotspots of antibiotic resistance genes, linking plastic pollution to one of the most pressing public health threats of the century. Tire wear particles, an often-overlooked category of microplastic pollution, add another contaminant stream to marine and freshwater systems. Because adsorption depends on polymer type, degree of weathering, and environmental chemistry, the review suggests that risk assessments relying on pristine, spherical, laboratory-grade particles may systematically misrepresent real-world exposures. Water treatment plants remove some microplastics, but the smallest fractions largely pass through conventional systems, and no current technology eliminates the chemical cargoes that particles carry once dispersed.

The authors conclude that microplastic-mediated contaminant exposure has become an emerging concern in environmental health sciences that demands integrated research approaches. Understanding the full risk requires connecting environmental chemistry, microbial ecology, toxicology, and human pharmacokinetics in a single analytical framework. As evidence of microplastics in human tissues continues to mount, the question is no longer whether people are exposed to these particles and their chemical hitchhikers, but how much of that combined exposure translates into internal dose and, ultimately, disease. The review makes clear that answering that question will require the kind of quantitative, mechanistic, cross-disciplinary effort that has transformed risk assessment in pharmaceutical science, now applied to one of the most diffuse pollution problems of the modern age.

Tae Gyu Oh, Ph.D., an assistant professor of oncology science at the University of Oklahoma College of Medicine and lead author of the study, highlights the pressing concern: “Exposure to microplastics is inevitable. Their presence in human tissues has been confirmed across multiple studies. However, we wanted to investigate how microplastic exposure interacts with a high-fat, high-cholesterol diet, known to independently induce liver damage.” The study offers compelling evidence that the combination of a typical Western diet and microplastic exposure exacerbates liver injury, potentially accelerating the progression of metabolic liver diseases.

Central to the study is the focus on polyethylene, the most prevalent plastic polymer globally, commonly found in everyday items such as plastic bags and milk containers. The research team administered polyethylene microplastics to mice over eight weeks, with one cohort receiving a standard diet and another subjected to a diet mimicking metabolic dysfunction-associated steatohepatitis (MASH). This severe form of fatty liver disease is characterized by inflammation and liver cell damage, often culminating in cirrhosis and liver failure if untreated.

The findings were striking: mice consuming the high-fat diet alongside microplastic exposure exhibited blood markers indicating liver injury more than twice as elevated as those on a standard diet experiencing similar exposure. This synergistic effect underscores the intricate interplay between environmental pollutants and diet-induced metabolic stressors, intensifying hepatic damage beyond what each factor causes independently.

To unravel the molecular and cellular underpinnings of this phenomenon, the research employed an array of sophisticated analytical techniques, culminating in the use of spatial transcriptomics. Unlike conventional bulk transcriptomic approaches, which average gene expression across millions of cells and can obscure localized responses, spatial transcriptomics enables researchers to map transcriptional activity within intact tissue sections at near single-cell resolution. This technique revealed precise “hot spots” of inflammation and tissue injury within the liver, a breakthrough insight unattainable by earlier methodologies.

Analysis of gene regulatory networks through spatial transcriptomics indicated a pivotal role for PPAR-alpha (peroxisome proliferator-activated receptor-alpha), a nuclear receptor that orchestrates fat metabolism and energy homeostasis in liver cells. PPAR-alpha appears to engage in cross-talk with Anxa2, a gene implicated in tissue repair and membrane dynamics. The altered activity of this axis in microplastic-exposed livers suggests that microplastics may disrupt the liver’s natural defense and regenerative processes, impairing its capacity to recover from metabolic insults.

This discovery has profound implications for understanding the mechanistic pathways by which environmental contaminants like microplastics contribute to liver pathology. The perturbation of PPAR-alpha and Anxa2 signaling potentially links microplastic exposure with the dysregulation of lipid metabolism and compromised repair, exacerbating the severity of conditions such as nonalcoholic fatty liver disease (NAFLD) and MASH.

While these findings were generated in a murine model, they establish an essential framework that informs potential human health risks. Given the parallels between murine and human liver physiology, it is plausible that microplastic exposure combined with high-fat diets could similarly predispose humans to aggravated liver damage. However, the researchers caution that further studies are necessary to confirm this translation and to elucidate the long-term implications for populations worldwide.

Dr. Oh emphasizes the broader relevance of this research: “Microplastics are now inextricably linked to daily life, yet their biological impact is only beginning to be understood. Through advanced spatial transcriptomic mapping, we have visualized the precise loci of hepatic damage induced by microplastics, revealing a novel environmental dimension to liver disease pathogenesis.” This nuanced comprehension paves the way for future investigations targeting environmental and dietary risk factors in liver health.

Moreover, these insights open avenues for therapeutic targeting. Modulating the PPAR-alpha-Anxa2 pathway could become a strategy to mitigate microplastic-induced liver injury or fortify the liver’s resilience against environmental toxins. Understanding such molecular crosstalk also facilitates improved diagnostic markers sensitive to environmental damage, allowing for earlier intervention in vulnerable populations.

This pioneering study exemplifies the intersection of environmental health, genomics, and hepatology, demonstrating how innovative technologies can elucidate complex biological interactions. It underscores the urgent need to address microplastic pollution not only as an ecological crisis but as a public health priority, particularly in societies where high-fat diets are prevalent.

As humanity grapples with escalating plastic waste and its fragmentary descent into invisible pollutants, research such as this serves as a clarion call for comprehensive strategies. Reducing plastic production, enhancing waste management, and fostering healthier dietary practices collectively form the cornerstone of mitigating hidden dangers to liver health and overall well-being.

The University of Oklahoma study, titled “Spatial Transcriptome Mapping Identifies Ppara-Anxa2 Crosstalk in Microplastic-Induced Hepatotoxicity,” stands as a seminal contribution offering unprecedented mechanistic clarity. Through employing spatial transcriptomics, the researchers have achieved a level of resolution that redefines how environmental toxicology and metabolic disease research can coalesce to confront emergent health threats posed by our plastic-saturated environment.

Subject of Research: Animals
Article Title: Spatial transcriptome mapping identifies Ppara-Anxa2 cross-talk in microplastic-induced hepatotoxicity
News Publication Date: 17-Jun-2026
Web References: https://doi.org/10.1126/sciadv.aec8681
References: Oh, T.G., Jung, W., Joshi, A.D., et al. Spatial Transcriptome Mapping Identifies Ppara-Anxa2 Crosstalk in Microplastic-Induced Hepatotoxicity. Science Advances, 2026.
Image Credits: University of Oklahoma
Keywords: Microplastics, Liver Disease, Fatty Liver Disease, Polyethylene, High-Fat Diets, Spatial Transcriptomics, PPAR-alpha, Anxa2, Hepatotoxicity, Environmental Health, Metabolic Dysfunction, Inflammation

Recent studies have uncovered that microplastics can be detected in various human tissues, including blood, the brain, the placenta, breast milk, and alarmingly, within bone tissue itself. This revelation underscores the potential for microplastics to harbor serious implications for public health, especially concerning osteoporosis and other metabolic bone disorders. A systematic review published in the journal Osteoporosis International highlights these concerns, revealing that microplastics can adversely affect bone health in multiple ways.

The pivotal research, conducted by a team from the Laboratory for Mineral and Bone Studies in Nephrology at the State University of Campinas, Brazil, evaluated 62 scientific articles to substantiate the link between microplastic exposure and compromised bone integrity. The findings demonstrated that microplastics can impair osteogenic processes. Specifically, they have been found to interfere with the function of bone marrow stem cells, engendering an increase in osteoclasts—cells responsible for bone resorption. In this context, the presence of elevated osteoclast levels could significantly degrade bone tissue, exacerbating conditions like osteoporosis.

Microplastics’ detrimental effects extend beyond immediate cellular activity. Studies on animals have indicated that exposure to microplastics accelerates osteoclast senescence, compromising overall bone microstructure and leading to dysplasia—a pathological condition characterized by abnormal bone growth. The consequences are grave, with potential outcomes including weakened bones, deformities, and an increased risk of pathological fractures that could impact quality of life and functional mobility.

As noted by leading researcher Rodrigo Bueno de Oliveira, microplastics’ influence on bone health is profound and multifaceted. In vitro studies using bone cell tissue have established that microplastics not only impair cell viability but also hasten cellular aging and provoke inflammatory responses. These cellular-level disruptions could ultimately contribute to systemic effects that may manifest as more serious health concerns in humans over time.

The implications of microplastics infiltrating bone tissue are particularly concerning. There’s a plausible theory that microplastics could disrupt bone metabolism, particularly influencing the delicate balance necessary for maintaining both bone density and overall skeletal integrity. Even more troubling is the potential pathway for microplastics to enter the bloodstream, raising questions about their effects on various organ systems and overall metabolic health.

Encouraged by these findings, Oliveira’s research team is initiating a project to critically evaluate the connection between microplastic exposure and the progression of metabolic bone diseases via animal models. Their forthcoming studies will specifically focus on assessing the impact of microplastic exposure on the biomechanical strength of rodent femurs, a promising line of inquiry that could yield illuminating insights into the overarching theme of environmental health and disease correlation.

In an era where the aging population is already straining health care systems globally, the risk of osteoporosis-related fractures looms larger than ever. Projections by the International Osteoporosis Foundation indicate that the incidence of osteoporosis will rise dramatically by 2050, with an estimated 32% increase in fractures worldwide. This reality necessitates a comprehensive understanding of all potential influences on bone health, particularly those that are environmental and modifiable, such as microplastic exposure.

Current strategies for mitigating fracture risk primarily involve lifestyle modifications, including regular physical exercise and nutritional interventions. However, the increasing visibility of environmental factors—namely, the pervasive presence of microplastics—demands urgent attention and research. As Oliveira’s work suggests, establishing microplastics as a controllable environmental factor may be crucial in addressing the rise in osteoporosis and fractures, offering novel insights into prevention strategies.

At the core of this research lies a profound message about the intersection of our environment and health. By paralleling the damaging environmental practices contributing to plastic pollution with the potential health risks manifested in human biology, scientists pave the way for a broader understanding of how human activities inadvertently foster health crises. Ultimately, this underscores a vital need for public awareness and research funding focused on understanding microplastics’ implications.

Moreover, the collaboration between institutions such as the São Paulo Research Foundation (FAPESP) is essential in providing the necessary resources to facilitate such groundbreaking research. By bridging local researchers with international experts, FAPESP fosters an environment ripe for innovation and discovery. This study’s findings could not only reshape public policies regarding environmental health but might also influence individual behavior towards plastic consumption and waste management.

In summary, as the scientific community delves deeper into the effects of microplastics, it becomes increasingly apparent that these tiny particles pose significant challenges to both the environment and human health. Through rigorous research and an unwavering commitment to uncovering the truth, we can better understand the trajectory of microplastics and their role within the complex web of life. As we strive to mitigate the impacts of plastic pollution, awareness and proactive measures are crucial in preserving human health and ensuring the longevity of our natural ecosystems.

Subject of Research: Microplastics and Bone Health
Article Title: Effects of microplastics on the bones: a comprehensive review
News Publication Date: 24-Jun-2025
Web References: Osteoporosis International
References: None available
Image Credits: Mariana Cassani de Oliveira/LEMON/FCM-UNICAMP

Keywords

Microplastics, osteoporosis, bone health, environmental health, ecological impact, metabolic bone diseases, plastic pollution, skeletal integrity, public health.